UNIVERSAL HEALTH SERVICES INC (UHS) Share buybacks
- Total buybacks · last 12 months (USD): Value $1.07B; Formula and calculation Trailing-year cash paid for share repurchases. Period ending 2026-06-30..
- Buyback yield · 12 months: Value (m); Formula and calculation Cash paid for share repurchases / current market cap. Period ending 2026-06-30..
Share buybacks
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total buybacks · last 12 months (USD) | $1.07B | Trailing-year cash paid for share repurchases. Period ending 2026-06-30. |
| Buyback yield · 12 months | (m) | Cash paid for share repurchases / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Buybacks · 12 months | 1.07B USD | Payments for Repurchase of Common Stock |
| Market cap | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total buybacks | Market cap (USD) | Buyback yield |
|---|---|---|---|
| 2026-06-30 | $1.07B | (m) | (m) |
| 2026-03-31 | $908.41M | (m) | (m) |
| 2025-12-31 | $967.95M | (m) | (m) |
| 2025-09-30 | $866.11M | (m) | (m) |
| 2025-06-30 | $811.31M | (m) | (m) |
| 2025-03-31 | $752.05M | (m) | (m) |
| 2024-12-31 | $670.75M | (m) | (m) |
| 2024-09-30 | $582.61M | (m) | (m) |
| 2024-06-30 | $575.59M | (m) | (m) |
| 2024-03-31 | $604.41M | (m) | (m) |
| 2023-12-31 | $547.36M | (m) | (m) |
| 2023-09-30 | $494.87M | (m) | (m) |
| 2023-06-30 | $477.49M | (m) | (m) |
| 2023-03-31 | $552.45M | (m) | (m) |
| 2022-12-31 | $832.92M | (m) | (m) |
| 2022-09-30 | $1.17B | (m) | (m) |
| 2022-06-30 | $1.42B | (m) | (m) |
| 2022-03-31 | $1.58B | (m) | (m) |
| 2021-12-31 | $1.22B | (m) | (m) |
| 2021-09-30 | $777.29M | (m) | (m) |
| 2021-06-30 | $374.75M | (m) | (m) |
| 2021-03-31 | $42.09M | (m) | (m) |
| 2020-12-31 | $206.72M | (m) | (m) |
| 2020-09-30 | $382.63M | (m) | (m) |
| 2020-06-30 | $475.91M | (m) | (m) |
| 2020-03-31 | $798.81M | (m) | (m) |
| 2019-12-31 | $770.50M | (m) | (m) |
| 2019-09-30 | $724.14M | (m) | (m) |
| 2019-06-30 | $757.29M | (m) | (m) |
| 2019-03-31 | $531.77M | (m) | (m) |
| 2018-12-31 | $397.43M | (m) | (m) |
| 2018-09-30 | $382.79M | (m) | (m) |
| 2018-06-30 | $351.72M | (m) | (m) |
| 2018-03-31 | $344.68M | (m) | (m) |
| 2017-12-31 | $364.40M | (m) | (m) |
| 2017-09-30 | $299.07M | (m) | (m) |
| 2017-06-30 | $261.70M | (m) | (m) |
| 2017-03-31 | $211.50M | (m) | (m) |
| 2016-12-31 | $353.38M | (m) | (m) |
| 2016-09-30 | $377.10M | (m) | (m) |
| 2016-06-30 | $380.76M | (m) | (m) |
| 2016-03-31 | $352.06M | (m) | (m) |
| 2015-12-31 | $209.78M | (m) | (m) |
| 2015-09-30 | $167.32M | (m) | (m) |
| 2015-06-30 | $133.13M | (m) | (m) |
| 2015-03-31 | $115.52M | (m) | (m) |
| 2014-12-31 | $100.75M | (m) | (m) |
| 2014-09-30 | $68.31M | (m) | (m) |
| 2014-06-30 | $41.60M | (m) | (m) |
| 2014-03-31 | $27.17M | (m) | (m) |
| 2013-12-31 | $27.20M | (m) | (m) |
| 2013-09-30 | $31.66M | (m) | (m) |
| 2013-06-30 | $37.60M | (m) | (m) |
| 2013-03-31 | $31.16M | (m) | (m) |
| 2012-12-31 | $19.15M | (m) | (m) |
| 2012-09-30 | $25.63M | (m) | (m) |
| 2012-06-30 | $57.25M | (m) | (m) |
| 2012-03-31 | $59.33M | (m) | (m) |
| 2011-12-31 | $60.48M | (m) | (m) |
| 2011-09-30 | $52.10M | (m) | (m) |
| 2011-06-30 | $13.99M | (m) | (m) |
| 2011-03-31 | $12.54M | (m) | (m) |
| 2010-12-31 | $11.53M | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) |
| 2009-12-31 | $63.29M | (m) | (m) |
| 2009-09-30 | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) |
| 2008-12-31 | $149.40M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.